212 related articles for article (PubMed ID: 33056990)
1. Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation.
Napoli M; Li X; Ackerman HD; Deshpande AA; Barannikov I; Pisegna MA; Bedrosian I; Mitsch J; Quinlan P; Thompson A; Rajapakshe K; Coarfa C; Gunaratne PH; Marchion DC; Magliocco AM; Tsai KY; Flores ER
Nat Commun; 2020 Oct; 11(1):5156. PubMed ID: 33056990
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
Escoll M; Gargini R; Cuadrado A; Anton IM; Wandosell F
Oncogene; 2017 Jun; 36(25):3515-3527. PubMed ID: 28166194
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
4. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
[TBL] [Abstract][Full Text] [Related]
5. TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway.
Su X; Napoli M; Abbas HA; Venkatanarayan A; Bui NHB; Coarfa C; Gi YJ; Kittrell F; Gunaratne PH; Medina D; Rosen JM; Behbod F; Flores ER
Oncogene; 2017 Apr; 36(17):2377-2393. PubMed ID: 27869165
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
7. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
[TBL] [Abstract][Full Text] [Related]
9. Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.
Shah VV; Duncan AD; Jiang S; Stratton SA; Allton KL; Yam C; Jain A; Krause PM; Lu Y; Cai S; Tu Y; Zhou X; Zhang X; Jiang Y; Carroll CL; Kang Z; Liu B; Shen J; Gagea M; Manu SM; Huo L; Gilcrease M; Powell RT; Guo L; Stephan C; Davies PJ; Parker-Thornburg J; Lozano G; Behringer RR; Piwnica-Worms H; Chang JT; Moulder SL; Barton MC
Nat Commun; 2021 Sep; 12(1):5389. PubMed ID: 34508101
[TBL] [Abstract][Full Text] [Related]
10. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
[TBL] [Abstract][Full Text] [Related]
11. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.
Su X; Chakravarti D; Cho MS; Liu L; Gi YJ; Lin YL; Leung ML; El-Naggar A; Creighton CJ; Suraokar MB; Wistuba I; Flores ER
Nature; 2010 Oct; 467(7318):986-90. PubMed ID: 20962848
[TBL] [Abstract][Full Text] [Related]
12. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
13. Functions of TAp63 and p53 in restraining the development of metastatic cancer.
Tan EH; Morton JP; Timpson P; Tucci P; Melino G; Flores ER; Sansom OJ; Vousden KH; Muller PA
Oncogene; 2014 Jun; 33(25):3325-33. PubMed ID: 23873029
[TBL] [Abstract][Full Text] [Related]
14. TAp63 induces senescence and suppresses tumorigenesis in vivo.
Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
[TBL] [Abstract][Full Text] [Related]
15. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
Ye Y; Tang X; Sun Z; Chen S
Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
[TBL] [Abstract][Full Text] [Related]
16. Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
Wang X; Su D; Qin Z; Chen Z
Gene; 2020 Jan; 722():144057. PubMed ID: 31430519
[TBL] [Abstract][Full Text] [Related]
17. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
[TBL] [Abstract][Full Text] [Related]
19. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
[TBL] [Abstract][Full Text] [Related]
20. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
Nout RA; Bosse T; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; van Eijk R; Ter Haar NT; Smit VT
Gynecol Oncol; 2012 Sep; 126(3):466-73. PubMed ID: 22609107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
